Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease breast cancer
Symptom C0948265|metabolic syndrome
Sentences 15
PubMedID- 21249376 Objective: this study was aimed to assess the prevalence of metabolic syndrome in patients with breast cancer and the independent effect of metabolic syndrome on breast cancer risk.
PubMedID- 26030767 Results: presence of metabolic syndrome was associated with significantly increased breast cancer risk in all women (hr 1.52, 95%ci 1.14-2.02).
PubMedID- 21964613 A retrospective review of the metabolic syndrome in women diagnosed with breast cancer and correlation with estrogen receptor.
PubMedID- 25979299 Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer.
PubMedID- 19851862 The association of metabolic syndrome with triple-negative breast cancer.
PubMedID- 21890443 metabolic syndrome and incidence of liver and breast cancers in japan.
PubMedID- 22740197 Several studies have examined the association of the individual components of the metabolic syndrome with breast cancer.
PubMedID- 26175188 Adherence to wcrf/aicr cancer prevention recommendations and metabolic syndrome in breast cancer patients.
PubMedID- 25653879 metabolic syndrome is associated with increased breast cancer risk: a systematic review with meta-analysis.
PubMedID- 24319454 Due to a higher prevalence of metabolic syndrome in breast cancer survivors, lifestyle interventions are needed to prevent chronic diseases associated with obesity.
PubMedID- 25979298 Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer.
PubMedID- 24344007 The relationship of insulin resistance and metabolic syndrome with known breast cancer prognostic factors in postmenopausal breast cancer patients.
PubMedID- 23050155 breast cancer patients with metabolic syndrome undergoing chemotherapy were found to have an overall poor response to treatment and those patients who specifically had high blood glucose levels were noted to have increased rates of disease progression 2.
PubMedID- 25083463 metabolic syndrome in breast cancer.
PubMedID- 25233884 Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer.

Page: 1